Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer
Proceedings of the National Academy of Sciences · 25.11.2025 · 122 (47)
DOI: 10.1073/pnas.2504718122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.11.2025. Verfasst von Xue Yang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Nurturing Center of Jiangsu Province for State Laboratory of Artificial Intelligence Imaging and Interventional Radiology, Z…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Tumor-Associated Macrophages, STING Protein. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation), MOST | National Key Research and Development Program of China (NKPs).
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, largely due to its highly immunosuppressive tumor microenvironment (TME), which fuels metastasis and resistance to immunotherapy. Through comprehensive analysis of single-cell RNA sequencing datasets, we identified multiple heterogeneous tumor-associated macrophage (TAMs) subpopulations as key regulators of PDAC progression, which coexpress MRC1 and exert their effects by actively suppressing antitumor immune responses. To overcome this barrier, we developed a spatiotemporal macrophage reprogramming platform that leverages STING phase separation to reprogram TAM plasticity and reshape the immune landscape. This system, MRC1-targeting peptide–M@BLZ945 (PMMB), integrates a colony-stimulating factor 1 receptor (CSF-1R) inhibitor and a STING agonist within a macrophage-mimetic nanostructure, enabling sequential, controlled reprogramming of TAMs. By leveraging STING phase separation, PMMB stabilizes TAMs in an antitumor CD80 + phenotype while preventing excessive inflammation, achieving durable immune activation. In preclinical models, PMMB not only suppresses both primary and metastatic PDAC but also enhances CD8 + T cell infiltration, reinvigorates anti-PD-1 therapy responses, and mitigates immune exhaustion. These findings establish spatiotemporal macrophage circuit engineering via STING phase separation as a cross-scale strategy to override PDAC’s immune barriers and drive next-generation macrophage-targeted immunotherapy. This study paves the way for rationally designed, precision macrophage modulation strategies in solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Nurturing Center of Jiangsu Province for State Laboratory of Artificial Intelligence Imaging and Interventional Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing 210009,…
- Department of Pharmaceutics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
- Department of Microbiology and Immunology, Medical School, Southeast University, Nanjing 210009, China.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119074, Singapore.
- Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore.
- Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore.
ORCID-Profile: Zebin Xiao, Xiaoyuan Chen, Shenghong Ju
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- JST | Natural Science Foundation of Jiangsu Province (Jiangsu Natural Science Foundation)
- MOST | National Key Research and Development Program of China (NKPs)
- National University of Singapore (NUS)
- MOH | National Medical Research Council (NMRC)
- DSI | National Research Foundation (NRF)
Zitieren
APA
Yang, X., Wang, Y., Zhou, J., Li, S., Ye, J., Sun, Y., He, M., Fan, K., Chen, Z., Tian, F., Zhao, B., Zhang, J., Xie, J., Xiao, Z., Chen, X., & Ju, S. (2025). Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer. Proceedings of the National Academy of Sciences, 122(47). https://doi.org/10.1073/pnas.2504718122
Vancouver
Yang X, Wang Y, Zhou J, Li S, Ye J, Sun Y, et al. Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer. Proceedings of the National Academy of Sciences. 2025;122(47). doi:10.1073/pnas.2504718122
BibTeX
@article{Yang2025,
author = {Yang, Xue and Wang, Yinlu and Zhou, Jiaxin and Li, Siyu and Ye, Jin and Sun, Yu and He, Mengning and Fan, Kai and Chen, Zixin and Tian, Fangzheng and Zhao, Ben and Zhang, Jianqiong and Xie, Jinbing and Xiao, Zebin and Chen, Xiaoyuan and Ju, Shenghong},
title = {Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {47},
doi = {10.1073/pnas.2504718122}
}
EUVIMED